I played these 25 cards the most and built so many decks around them — or at least dreamed how they might function in the ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Especially on X, algorithmic culture is characterized by ceaseless iteration: Everything that’s happening is piled atop all ...

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

The Telecom Regulatory Authority of India (TRAI) has mandated that entities regulated by the Insurance Regulatory and Development Authority of India (IRDAI) adopt the ‘1600’ series numbers by February ...

Run Away, the new Harlan Coben thriller starring James Nesbitt and Ruth Jones, has stormed to the top of the Netflix charts.

Apple TV's latest hit has many talking, as Vince Gilligan's Pluribus is number one on the streaming platform's charts! Read ...

The finale of Apple TV’s ‘Pluribus’ ends with a bang, with the long-awaited meeting between Carol (Rhea Seehorn) and Manousos ...

"How heroic are you if you only do it when you’re threatened?” Seehorn ponders in a deep-dive conversation with The Hollywood Reporter about the cliffhanger ending to the Vince Gilligan series.